Dynamic monitoring serum CD30 in predicting acute rejection in kidney transplant recipients
10.3760/cma.j.issn.0254-1785.2014.10.004
- VernacularTitle:动态监测血清sCD30在肾移植后急性排斥反应预警中的意义
- Author:
Xuzhen WANG
;
Wujun XUE
;
Xiaohui TIAN
;
Jin ZHENG
;
Puxun TIAN
;
Xiaoming DING
- Publication Type:Journal Article
- Keywords:
kidney transplant;
Acute rejection;
sCD30
- From:
Chinese Journal of Organ Transplantation
2014;35(10):590-593
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the significance of serum CD30 in predicting acute rejection in kidney transplant recipients.Method A total of 106 kidney transplant recipients were recruited in this prospective six months follow-up study from December 2010 to October 2012.According to the clinical outcome,the subjects were devided into stable renal function group (72 cases) and acute rejection group (34 cases).Twenty healthy subjects were choosed as controls.Serum sCD30 levels were detected by ELISA.The whole peripheral blood samples were collected from all recipients before transplantation,at days 7,14,21 and 28 post-transplantation,and at months 2,3,4,5 and 6 posttransplantation.Additional blood samples were collected for on the days that acute rejection occurred and reversed.Result Preoperative serum sCD30 levels were 33.42 ± 11.49 and 26.5 1 ± 13.70μg/L in AR group and stable group respectively.When acute rejection occurred,serum sCD30 levels in AR group was 50.38 ± 12.10μg/L,which was significantly higher than stable group (20.03 ± 6.68μg/L,P<0.05) and healthy control group (13.57 ± 5.56 ng/L,P<0.05).After the anti-rejection therapy,serum sCD30 levels decreased to 15.31 ± 6.37μg/L,which was lower than that before the therapy started (50.38± 12.10 μg/L,P<0.05).Elevated preoperative serum sCD30 levels suggested a higher risk of acute rejection in kidney transplant recipients,with Cutoff values of 24.96 μg/L,and the sensitivity and specificity were 91.30% and 84.21% respectively.Conclusion Serum sCD30 levels can predict and assess the risks of rejection episodes in kidney transplant recipients.